Well Referenced

Tag: 25-hydroxyvitamin D

Correction: Serum 25-Hydroxyvitamin D Concentrations ≥40 ng/ml Are Associated with >65% Lower Cancer Risk: Pooled Analysis of Randomized Trial and Prospective Cohort Study

This 2018 correction pertains to the 2016 study that pooled data from a randomized clinical trial and a prospective cohort to assess the relationship between serum 25-hydroxyvitamin D [25(OH)D] levels and cancer risk in women aged 55 and older. The original analysis demonstrated that women with serum 25(OH)D concentrations ≥40

Read More »
June 26, 2025 No Comments

Obesity Induced Magnesium Deficiency Can Be Treated by Vitamin D Supplementation

This randomized controlled trial investigated the effect of high-dose vitamin D supplementation on serum magnesium levels in obese and non-obese women aged 17–50. Eighty-two participants from Tabriz, Iran, were divided into obese (stage 1 and 2) and non-obese groups. Baseline measurements indicated that obese women had significantly lower serum magnesium

Read More »
June 26, 2025 No Comments

Vitamin D, sunlight, and the epidemiology of prostate cancer

This 2012 review examines the relationship between vitamin D, sunlight exposure, and prostate cancer risk. Ecological studies indicate an inverse correlation between ultraviolet (UV) radiation levels and prostate cancer mortality. Human prostate cells possess receptors for 1,25-dihydroxyvitamin D, which exhibits anticancer effects in vitro and in animal models. While some

Read More »
June 26, 2025 No Comments

Phase 2 study examining magnesium-dependent tinnitus

This 2012 cohort study published in Magnesium Research analyzed data from 4,107 U.S. adults in the NHANES 2001–2006 dataset to examine the relationship between magnesium intake and serum vitamin D levels. The findings showed that higher magnesium intake was significantly associated with increased serum 25(OH)D levels and a lower risk

Read More »
June 26, 2025 No Comments